ANAIT GALFAIAN
Allopathic & Osteopathic Physicians|Family Medicine GLENDALE, CA NPI 1447358981
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine CA Amgen Inc. All categories
General Payments — all program years on this page
$14,207.74
- Category: General Payments
- Program years: PY2018–2024
- Record count: 208
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $556.69 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.69 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $251.96 | 3 |
| Novo Nordisk AS | $177.87 | 4 |
| OptiNose US, Inc. | $126.86 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096845338 | Novo Nordisk Inc | $10.22 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096955067 | Novo Nordisk Inc | $23.81 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097260887 | Novo Nordisk Inc | $121.18 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097805349 | Novo Nordisk Inc | $22.66 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111579459 | Amgen Inc. | $122.12 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111579461 | Amgen Inc. | $121.84 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117256345 | Amgen Inc. | $8.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142183612 | Optinose US, Inc. | $126.86 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.